Publisher： Bentham Science Publishers
E-ISSN： 1875-533x|23|1|36-59
ISSN： 0929-8673
Source： Current Medicinal Chemistry, Vol.23, Iss.1, 2016-01, pp. : 36-59
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
The angiotensin II type 1 receptor (AT1R) has been recently crystallized. A new era has emerged for the structure-based rational drug design and the synthesis of novel AT1R antagonists. In this critical review, the X-ray crystallographic data of commercially available AT1R antagonists in free form are analyzed and compared with the conformational analysis results obtained using a combination of NMR spectroscopy and Molecular Modeling. The same AT1R antagonists are docked and compared in terms of their interactions in their binding site using homology models and the crystallized AT1R receptor. Various aspects derived from these comparisons regarding rational drug design are outlined.
Related content
Access to resources
Recommend
G-protein coupled receptor kinases and their inhibitors
By Kassack M.U.
Expert Opinion on Therapeutic Patents, Vol. 10, Iss. 6, 2000-06 ,pp. :
G-protein coupled receptors bivalent ligands and drug design
By Halazy S.
Expert Opinion on Therapeutic Patents, Vol. 9, Iss. 4, 1999-04 ,pp. :
CNS & Neurological Disorders - Drug Targets (Formerly Current Drug Targets - CNS & Neurological Disorders), Vol. 13, Iss. 7, 2014-09 ,pp. :